BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30847751)

  • 41. Does partial cystectomy compromise oncologic outcomes for patients with bladder cancer compared to radical cystectomy? A matched case-control analysis.
    Knoedler JJ; Boorjian SA; Kim SP; Weight CJ; Thapa P; Tarrell RF; Cheville JC; Frank I
    J Urol; 2012 Oct; 188(4):1115-9. PubMed ID: 22901583
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reproductive organ involvement in female patients undergoing radical cystectomy for urothelial bladder cancer.
    Djaladat H; Bruins HM; Miranda G; Cai J; Skinner EC; Daneshmand S
    J Urol; 2012 Dec; 188(6):2134-8. PubMed ID: 23083874
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radical Cystectomy in Pathological T4a and T4b Bladder Cancer Patients: Is There Any Space for Sub Stratification?
    Moschini M; Zamboni S; Mattei A; Baumeister P; Di Bona C; Cornelius J; Shariat SF; Freschi M; Zaffuto E; Salonia A; Montorsi F; Briganti A; Colombo R; Gallina A;
    Urol Int; 2019; 102(3):269-276. PubMed ID: 30695782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lymph node density vs. the American Joint Committee on Cancer TNM nodal staging system in node-positive bladder cancer in patients undergoing extended or super-extended pelvic lymphadenectomy.
    Lee D; Yoo S; You D; Hong B; Cho YM; Hong JH; Kim CS; Ahn H; Ro JY; Jeong IG
    Urol Oncol; 2017 Apr; 35(4):151.e1-151.e7. PubMed ID: 28139370
    [TBL] [Abstract][Full Text] [Related]  

  • 45. External Validation of Bladder Cancer Predictive Nomograms for Recurrence, Cancer-Free Survival and Overall Survival following Radical Cystectomy.
    Brooks M; Godoy G; Sun M; Shariat SF; Amiel GE; Lerner SP
    J Urol; 2016 Feb; 195(2):283-9. PubMed ID: 26343350
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?
    Herr HW; Sogani PC
    J Urol; 2001 Oct; 166(4):1296-9. PubMed ID: 11547061
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Deceptive muscle invasive bladder cancer recurrence with benign biopsy foci after bladder sparing treatment.
    Xu C; Zeng S; Zhang Z; Song R; Ma C; Chen X; Sun Y
    Medicine (Baltimore); 2015 Jun; 94(22):e898. PubMed ID: 26039120
    [TBL] [Abstract][Full Text] [Related]  

  • 48. P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors.
    Kassouf W; Spiess PE; Brown GA; Munsell MF; Grossman HB; Siefker-Radtke A; Dinney CP; Kamat AM
    Eur Urol; 2007 Sep; 52(3):769-74. PubMed ID: 17434254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term outcomes of salvage radical cystectomy for recurrent urothelial carcinoma of the bladder following partial cystectomy.
    Bruins HM; Wopat R; Mitra AP; Cai J; Miranda G; Skinner EC; Daneshmand S
    BJU Int; 2013 Mar; 111(3 Pt B):E37-42. PubMed ID: 22974410
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of preoperative thrombocytosis on pathological outcomes and survival in patients treated with radical cystectomy for bladder carcinoma.
    Moschini M; Suardi N; Pellucchi F; Rocchini L; La Croce G; Capitanio U; Briganti A; Damiano R; Montorsi F; Colombo R
    Anticancer Res; 2014 Jun; 34(6):3225-30. PubMed ID: 24922698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictive Effect of Preoperative Anemia on Long-Term Survival Outcomes with Non-Muscle Invasive Bladder Cancer.
    Celik O; Akand M; Keskin MZ; Ekin RG; Yoldas M; Ilbey YO
    Asian Pac J Cancer Prev; 2016; 17(4):1755-8. PubMed ID: 27221848
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Timing of Radical Cystectomy for bacillus Calmette-GuĂ©rin Failure: Comparison of Outcomes and Risk Factors for Prognosis.
    Haas CR; Barlow LJ; Badalato GM; DeCastro GJ; Benson MC; McKiernan JM
    J Urol; 2016 Jun; 195(6):1704-9. PubMed ID: 26807928
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sphincter-preserving extended resection for locally advanced rectosigmoid carcinoma involving the urinary bladder.
    Fuhrman GM; Talamonti MS; Curley SA
    J Surg Oncol; 1992 Jun; 50(2):77-80. PubMed ID: 1593889
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection.
    Holzbeierlein JM; Lopez-Corona E; Bochner BH; Herr HW; Donat SM; Russo P; Dalbagni G; Sogani PC
    J Urol; 2004 Sep; 172(3):878-81. PubMed ID: 15310988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The association of ABO blood type with disease recurrence and mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
    Gershman B; Moreira DM; Tollefson MK; Frank I; Cheville JC; Thapa P; Tarrell RF; Thompson RH; Boorjian SA
    Urol Oncol; 2016 Jan; 34(1):4.e1-9. PubMed ID: 26329815
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of partial and total cystectomy for colorectal cancer with histologically confirmed bladder invasion.
    Suh JW; Kim DW; Lee J; Yang IJ; Ahn HM; Oh HK; Kim JK; Lee H; Oh JJ; Lee S; Jeong SJ; Hong SK; Byun SS; Kang SB
    Surgery; 2024 Jun; ():. PubMed ID: 38851902
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Variability in surgical quality in a phase III clinical trial of radical cystectomy in patients with organ-confined, node-negative urothelial carcinoma of the bladder.
    Mata DA; Groshen S; Von Rundstedt FC; Skinner DG; Stadler WM; Cote RJ; Stein JP; Lerner SP
    J Surg Oncol; 2015 Jun; 111(7):923-8. PubMed ID: 25873574
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Local involvement of the urinary bladder in primary colorectal cancer: outcome with en-bloc resection.
    Winter DC; Walsh R; Lee G; Kiely D; O'Riordain MG; O'Sullivan GC
    Ann Surg Oncol; 2007 Jan; 14(1):69-73. PubMed ID: 17063308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.